Abstract
Introduction: Primary percutaneous coronary intervention (pPCI) presents standard treatment in patients with acute myocardial infarction. In order to predict the prognosis of patients with ST segment elevation myocardial infarction (STEMI), several risk scores have been developed. Aim: Comparison of the predictive value of three validated risk scores, regarding intrahospital, short-term (30-days) and long-term (1-year) mortality among patients with a diagnosis of STEMI treated with pPCI in the Catheterization lab, Clinical Center of Serbia. Material and methods: The retrospective study included 311 consecutive patients with a diagnosis of STEMI treated with pPCI in 2017. Patients with cardiogenic shock at admission were excluded. Data were analyzed from the electronic database. For every patient the value of CADILLAC, ZWOLLE and TIMI score was calculated. The predictive ability of the risk scores was compared by area under (AUC) the ROC (Receiver Operating Characteristic) curves. The short-term and long-term outcome of the patient was assessed by telephone and clinical contact. Results: The study population was 311 patients, with an average age of 61±10 years, of which 237 (76.2%) were male. Rates of intrahospital, mortality at 30 days and at one year after pPCI were 1.9%, 3.2%, 6.1%. All three test scores showed very good predictive value in short-term mortality, both intrahospital (0.962; 0.986; 0.964, p=ns within scores) and after 30 days (0.920; 0.956; 0.861, p=ns within scores), while after 1 year accuracy of CADILLAC and ZWOLLE was better than TIMI score (0.921; 0.905; 0.786, p vs. TIMI 0,0087 and 0,0567). The age, three-vessel coronary disease and lower admission hemoglobin were identified as independent predictors for one-year mortality by logistic regression analysis. Conclusion: Both CADILLAC and ZWOLLE showed a very good predictive ability for intrahospital, short and long-term mortality, while for TIMI score, comparable accuracy was observed only for a period of up to 30 days following pPCI.
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference19 articles.
1. Halkin A, Singh M, Nikolsky E, et al. Prediction of Mortality After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: The CADILLAC Risk Score. Journal of American College of Cardiology. 2005; 45(9):1397-1405;
2. Littnerova S, Kala P, Jarkovsky J, et al. GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction. PLoS One. 2015; 10(4);
3. Widimsky P, Wijns W, Fajadet J, et al. Reperfusion therapy for ST-Elevation Myocardial Infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010; 31(8):943-957;
4. Filipiak KJ, Kotlowski L, Grabowski M, et al. Comparison of the 7-year predictive value of six risk scores in acute coronary syndrome patients: GRACE, TIMI STEMI, TIMI NSTEMI, SIMPLE, ZWOLLE and BANACH. Kardiol Pol. 2014; 72(2):155-165;
5. Steg GP, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: Task Force on the management of STsegment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J. 2012; 33(20):2569-2619;